Transfusion Medicine Reviews
Volume 21, Issue 4 , Pages 273-286 , October 2007

Leukocyte Antigen and Antibody Detection Assays: Tools for Assessing and Preventing Pulmonary Transfusion Reactions

References 

  1. Brittingham TE. Immunologic studies on leukocytes. Vox Sang. 1957;2:242–248
  2. King KE, Shirey RS, Thoman SK, et al. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion. 2004;44:25–29
  3. Paglino JC, Pomper GJ, Fisch GS, et al. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion. 2004;44:16–24
  4. Yazer MH, Podlosky L, Clarke G, et al. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion. 2004;44:10–15
  5. Stroncek DF, Shapiro RS, Filipovich AH, et al. Prolonged neutropenia resulting from antibodies to neutrophil-specific antigen NB1 following marrow transplantation. Transfusion. 1993;33:158–163
  6. Stroncek DF, Leonard K, Eiber G, et al. Alloimmunization after granulocyte transfusions. Transfusion. 1996;36:1009–1015
  7. Sachs UJ, Bux J. TRALI after the transfusion of cross-match-positive granulocytes. Transfusion. 2003;43:1683–1686
  8. Popovsky MA, Abel MD, Moore SB. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis. 1983;128:185–189
  9. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985;25:573–577
  10. Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: Definition and review. Crit Care Med. 2005;33:721–726
  11. Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: Statement of a consensus panel. Transfusion. 2004;44:1774–1789
  12. Malissen M, Malissen B, Jordan BR. Exon/intron organization and complete nucleotide sequence of an HLA gene. Proc Natl Acad Sci U S A. 1982;79:893–897
  13. Germain RN, Malissen B. Analysis of the expression and function of class-II major histocompatibility complex-encoded molecules by DNA-mediated gene transfer. Annu Rev Immunol. 1986;4:281–315
  14. Yewdell JW, Bennink JR. The binary logic of antigen processing and presentation to T cells. Cell. 1990;62:203–206
  15. Goodfellow PN, Jones EA, Van H, et al. The beta2-microglobulin gene is on chromosome 15 and not in the HL-A region. Nature. 1975;254:267–269
  16. Trowsdale J, Ragoussis J, Campbell RD. Map of the human MHC. Immunol Today. 1991;12:443–446
  17. Bux J. Nomenclature of granulocyte alloantigens. ISBT Working Party on Platelet and Granulocyte Serology, Granulocyte Antigen Working Party. International Society of Blood Transfusion. Transfusion. 1999;39:662–663
  18. Lalezari P, Bernard GE. An isologous antigen-antibody reaction with human neutrophiles, related to neonatal neutropenia. J Clin Invest. 1966;45:1741–1750
  19. Boxer LA, Yokoyama M, Lalezari P. Isoimmune neonatal neutropenia. J Pediatr. 1972;80:783–787
  20. Huizinga TW, Kleijer M, Tetteroo PA, et al. Biallelic neutrophil Na-antigen system is associated with a polymorphism on the phospho-inositol-linked Fc gamma receptor III (CD16). Blood. 1990;75:213–217
  21. Huizinga TW, de Haas M, Kleijer M, et al. Soluble Fc gamma receptor III in human plasma originates from release by neutrophils. J Clin Invest. 1990;86:416–423
  22. Kissel K, Santoso S, Hofmann C, et al. Molecular basis of the neutrophil glycoprotein NB1 (CD177) involved in the pathogenesis of immune neutropenias and transfusion reactions. Eur J Immunol. 2001;31:1301–1309
  23. Caruccio L, Bettinotti M, Director-Myska AE, et al. The gene overexpressed in polycythemia rubra vera, PRV-1, and the gene encoding a neutrophil alloantigen, NB1, are alleles of a single gene, CD177, in chromosome band 19q13.31. Transfusion. 2006;46:441–447
  24. Stroncek DF, Skubitz KM, McCullough JJ. Biochemical characterization of the neutrophil-specific antigen NB1. Blood. 1990;75:744–755
  25. Santoso, S. The role of neutrophil antigens in cell-cell interactions. Vox Sang. 91 [Supplement 2], 4. 6-2-2006. Ref Type: Abstract
  26. Temerinac S, Klippel S, Strunck E, et al. Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. Blood. 2000;95:2569–2576
  27. de Haas M, Muniz-Diaz E, Alonso LG, et al. Neutrophil antigen 5b is carried by a protein, migrating from 70 to 95 kDa, and may be involved in neonatal alloimmune neutropenia. Transfusion. 2000;40:222–227
  28. Simsek S, van der Schoot CE, Daams M, et al. Molecular characterization of antigenic polymorphisms (Ond(a) and Mart(a)) of the beta 2 family recognized by human leukocyte alloantisera. Blood. 1996;88:1350–1358
  29. Hopkins KA, van Leeuwen A, Tardiff GN, et al. Lymphocytoxocity testing. In:  Zachary AA,  Teresi GA editor. ASHI Laboratory Manual. Lenexa, KS: American Society for Histocompatibility and Immunogenetics; 1990;p. 195–199[second]
  30. Sakaguchi K, Ono R, Tsujisaki M, et al. Anti-HLA-B7, B27, Bw42, Bw54, Bw55, Bw56, Bw67, Bw73 monoclonal antibodies: Specificity, idiotypes, and application for a double determinant immunoassay. Hum Immunol. 1988;21:193–207
  31. Parker KC, Bednarek MA, Hull LK, et al. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J Immunol. 1992;149:3580–3587
  32. Rotzschke O, Falk K, Stevanovic S, et al. Peptide motifs of closely related HLA class I molecules encompass substantial differences. Eur J Immunol. 1992;22:2453–2456
  33. Rivoltini L, Loftus DJ, Barracchini K, et al. Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy. J Immunol. 1996;156:3882–3891
  34. Sette A, Vitiello A, Reherman B, et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol. 1994;153:5586–5592
  35. Bunce M, O'Neill CM, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens. 1995;46:355–367
  36. Krausa P, Browning MJ. A comprehensive PCR-SSP typing system for identification of HLA-A locus alleles. Tissue Antigens. 1996;47:237–244
  37. Ng J, Hurley CK, Carter C, et al. Large-scale DRB and DQB1 oligonucleotide typing for the NMDP registry: Progress report from year 2. Tissue Antigens. 1996;47:21–26
  38. Itoh Y, Mizuki N, Shimada T, et al. High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics. 2005;57:717–729
  39. Itoh Y, Inoko H, Kulski JK, et al. Four-digit allele genotyping of the HLA-A and HLA-B genes in Japanese patients with Behcet's disease by a PCR-SSOP-Luminex method. Tissue Antigens. 2006;67:390–394
  40. Fulton RJ, McDade RL, Smith PL, et al. Advanced multiplexed analysis with the FlowMetrix system. Clin Chem. 1997;43:1749–1756
  41. Adams SD, Barracchini KC, Chen D, et al. Ambiguous allele combinations in HLA class I and class II sequence-based typing: When precise nucleotide sequencing leads to imprecise allele identification. J Transl Med. 2004;2:30,;2004
  42. Wang E, Adams S, Zhao Y, et al. A strategy for detection of known and unknown SNP using a minimum number of oligonucleotides applicable in the clinical settings. J Transl Med. 2003;1:4,;2003
  43. Bux J, Stein EL, Santoso S, et al. NA gene frequencies in the German population, determined by polymerase chain reaction with sequence-specific primers. Transfusion. 1995;35:54–57
  44. Kissel K, Hofmann C, Gittinger FS, et al. HNA-1a, HNA-1b, and HNA-1c (NA1, NA2, SH) frequencies in African and American blacks and in Chinese. Tissue Antigens. 2000;56:143–148
  45. Hessner MJ, Curtis BR, Endean DJ, et al. Determination of neutrophil antigen gene frequencies in five ethnic groups by polymerase chain reaction with sequence-specific primers. Transfusion. 1996;36:895–899
  46. Clague HD, Fung YL, Minchinton RM. Human neutrophil antigen-4a gene frequencies in an Australian population, determined by a new polymerase chain reaction method using sequence-specific primers. Transfus Med. 2003;13:149–152
  47. Sachs UJ, Reil A, Bauer C, et al. Genotyping of human neutrophil antigen-5a (Ond). Transfus Med. 2005;15:115–117
  48. Cardone JD, Bordin JO, Chiba AK, et al. Gene frequencies of the HNA-4a and -5a neutrophil antigens in Brazilian persons and a new polymerase chain reaction-restriction fragment length polymorphism method for HNA-5a genotyping. Transfusion. 2006;46:1515–1520
  49. Kissel K, Scheffler S, Kerowgan M, et al. Molecular basis of NB1 (HNA-2a, CD177) deficiency. Blood. 2002;99:4231–4233
  50. Parham P. Purification of immunologically active HLA-A and -B antigens by a series of monoclonal antibody columns. J Biol Chem. 1979;254:8709–8712
  51. Barnardo MC, Harmer AW, Shaw OJ, et al. Detection of HLA-specific IGG antibodies using single recombinant HLA alleles: the MonoLISA assay. Transplantation. 2000;70:531–536
  52. Pei R, Lee JH, Shih NJ, et al. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation. 2003;75:43–49
  53. Pei R, Lee J, Chen T, et al. Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum Immunol. 1999;60:1293–1302
  54. Pei R, Wang G, Tarsitani C, et al. Simultaneous HLA class I and class II antibodies screening with flow cytometry. Hum Immunol. 1998;59:313–322
  55. McCullough J, Clay M, Press C, et al. Granulocyte serology: A clinical and laboratory guide. Chicago: American Society of Clinical Pathologists Press; 1988;
  56. Bux J, Kober B, Kiefel V, et al. Analysis of granulocyte-reactive antibodies using an immunoassay based upon monoclonal-antibody–specific immobilization of granulocyte antigens. Transfus Med. 1993;3:157–162
  57. Metcalfe P, Waters AH. Location of the granulocyte-specific antigen LAN on the Fc-receptor III. Transfus Med. 1992;2:283–287
  58. Nishimura M, Takanashi M, Okazaki H, et al. Detection of anti-CD32 alloantibody in donor plasma implicated in development of transfusion-related acute lung injury. Cell Biochem Funct. 2005;25:179–183
  59. Fadeyi E, Muniz M, Wayne AS, et al. The transfusion of neutrophil-specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions. Transfusion. 2007;47:545–550
  60. Seeger W, Schneider U, Kreusler B, et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood. 1990;76:1438–1444
  61. Sachs UJ, Hattar K, Weissmann N, et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood. 2006;107:1217–1219
  62. Palfi M, Berg S, Ernerudh J, et al. A randomized controlled trial of transfusion-related acute lung injury: Is plasma from multiparous blood donors dangerous?. Transfusion. 2001;41:317–322
  63. Kopko PM, Marshall CS, MacKenzie MR, et al. Transfusion-related acute lung injury: Report of a clinical look-back investigation. JAMA. 2002;287:1968–1971
  64. Looney MR, Su X, Van Ziffle JA, et al. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest. 2006;116:1615–1623
  65. Toy P, Hollis-Perry KM, Jun J, et al. Recipients of blood from a donor with multiple HLA antibodies: A lookback study of transfusion-related acute lung injury. Transfusion. 2004;44:1683–1688
  66. Cooling L. Transfusion-related acute lung injury. JAMA. 2002;288:315–316

PII: S0887-7963(07)00042-9

doi: 10.1016/j.tmrv.2007.05.003

Transfusion Medicine Reviews
Volume 21, Issue 4 , Pages 273-286 , October 2007

Article Tools

* Image Usage & Resolution